As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

The secretary of the Department of Health and Human Services, or HHS, plays a significant role in every American’s access to health care and in the nation’s overall well-being.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

And remember, Medicare provides access to about 8,000 drugs ... but what I will tell you is there is a core of personnel at HHS, regardless of administration, that has done dramatically important ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

In a memo obtained by NPR, acting Health Secretary Dorothy Fink forbade staff from public communications on most matters ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.